A case–control study to evaluate the risk of agranulocytosis and neutropenia associated with the concomitant use of metamizole and fluoropyrimidine and oxaliplatin-based chemotherapy

Data sources

• Data source(s), other:
  Electronic health records
• Data sources (types):
  Electronic healthcare records (EHR)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No